Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-27022

Xla Wt + hs6st1 CRISPR, Yamamoto T et al. (2023)

Experiment + Assay: Xla Wt + hs6st1 CRISPR + NF17-18 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
CRISPR hs6st1 gRNA1 hs6st1
 NF stage 3 (4-cell) animal pole
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 17 to NF stage 18  
Expression Phenotypes (3):
decreased amount foxd3.L expression in cranial neural crest
decreased amount krt12.4.L expression in neural plate
decreased amount tfap2a.L expression in cranial neural crest
Source: Fig. S3 ABCD
Article: XB-ART-59537, PubMed